FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971270048> ?p ?o ?g. }

• W1971270048 endingPage "226" @default.
• W1971270048 startingPage "219" @default.
• W1971270048 abstract "Serum fibrosis marker levels during the lead-in treatment phase of patients enrolled in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial were determined.Week 0, 24, 48, and 72 serum samples were analyzed for YKL-40, tissue inhibitor of matrix metalloproteinase-1, amino-terminal peptide of type III procollagen (PIIINP), and hyaluronic acid (HA) levels. All 456 chronic hepatitis C (CHC) patients received peginterferon alfa 2a and ribavirin for 24 to 48 weeks.Mean age was 49.2 years, 71% were male, and 39% had cirrhosis. Lower pretreatment serum YKL-40, tissue inhibitor of matrix metalloproteinase-1, PIIINP, and HA levels were associated significantly with week-20 virologic response (P < .0001). In multivariate analysis, non-1 CHC genotype, non-black race, prior interferon monotherapy, and lower baseline serum aspartate aminotransferase/alanine aminotransferase levels and log(10)YKL-40 levels were associated independently with week-20 virologic response. Statistically significant declines in all marker levels were observed at week 72 compared with baseline in the 81 patients with a sustained virologic response, but not in the 72 patients with breakthrough or relapse. At weeks 24 and 48, significant increases were observed in serum PIIINP and HA levels compared with baseline in virologic responders and nonresponders (P < .0001).Pretreatment YKL-40 levels are an independent predictor of initial virologic response to peginterferon and ribavirin treatment. Levels of all 4 serum fibrosis markers decreased significantly in the SVR patients, consistent with reduced hepatic fibrogenesis. Measuring serum fibrosis marker levels before and after antiviral therapy may provide important prognostic information in CHC patients." @default.
• W1971270048 created "2016-06-24" @default.
• W1971270048 creator A5037326704 @default.
• W1971270048 creator A5037691277 @default.
• W1971270048 creator A5051411123 @default.
• W1971270048 creator A5063597784 @default.
• W1971270048 creator A5066255279 @default.
• W1971270048 creator A5077140895 @default.
• W1971270048 creator A5085461623 @default.
• W1971270048 date "2009-02-01" @default.
• W1971270048 modified "2023-10-17" @default.
• W1971270048 title "Serum Fibrosis Marker Levels Decrease After Successful Antiviral Treatment in Chronic Hepatitis C Patients With Advanced Fibrosis" @default.
• W1971270048 cites W1972662945 @default.
• W1971270048 cites W2000649393 @default.
• W1971270048 cites W2013302480 @default.
• W1971270048 cites W2016409892 @default.
• W1971270048 cites W2027545702 @default.
• W1971270048 cites W2034299263 @default.
• W1971270048 cites W2038866228 @default.
• W1971270048 cites W2039383406 @default.
• W1971270048 cites W2044269551 @default.
• W1971270048 cites W2049533426 @default.
• W1971270048 cites W2056408448 @default.
• W1971270048 cites W2056660646 @default.
• W1971270048 cites W2067435274 @default.
• W1971270048 cites W2076982556 @default.
• W1971270048 cites W2085261733 @default.
• W1971270048 cites W2119266617 @default.
• W1971270048 cites W2122317467 @default.
• W1971270048 cites W2133580842 @default.
• W1971270048 cites W2139590183 @default.
• W1971270048 cites W2143125362 @default.
• W1971270048 cites W2151769300 @default.
• W1971270048 doi "https://doi.org/10.1016/j.cgh.2008.10.034" @default.
• W1971270048 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3766729" @default.
• W1971270048 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19068241" @default.
• W1971270048 hasPublicationYear "2009" @default.
• W1971270048 type Work @default.
• W1971270048 sameAs 1971270048 @default.
• W1971270048 citedByCount "41" @default.
• W1971270048 countsByYear W19712700482012 @default.
• W1971270048 countsByYear W19712700482014 @default.
• W1971270048 countsByYear W19712700482015 @default.
• W1971270048 countsByYear W19712700482016 @default.
• W1971270048 countsByYear W19712700482017 @default.
• W1971270048 countsByYear W19712700482018 @default.
• W1971270048 countsByYear W19712700482019 @default.
• W1971270048 countsByYear W19712700482020 @default.
• W1971270048 countsByYear W19712700482021 @default.
• W1971270048 countsByYear W19712700482022 @default.
• W1971270048 crossrefType "journal-article" @default.
• W1971270048 hasAuthorship W1971270048A5037326704 @default.
• W1971270048 hasAuthorship W1971270048A5037691277 @default.
• W1971270048 hasAuthorship W1971270048A5051411123 @default.
• W1971270048 hasAuthorship W1971270048A5063597784 @default.
• W1971270048 hasAuthorship W1971270048A5066255279 @default.
• W1971270048 hasAuthorship W1971270048A5077140895 @default.
• W1971270048 hasAuthorship W1971270048A5085461623 @default.
• W1971270048 hasBestOaLocation W19712700481 @default.
• W1971270048 hasConcept C126322002 @default.
• W1971270048 hasConcept C203014093 @default.
• W1971270048 hasConcept C2522874641 @default.
• W1971270048 hasConcept C2776235749 @default.
• W1971270048 hasConcept C2776408679 @default.
• W1971270048 hasConcept C2776455275 @default.
• W1971270048 hasConcept C2777214474 @default.
• W1971270048 hasConcept C2780040827 @default.
• W1971270048 hasConcept C2780559512 @default.
• W1971270048 hasConcept C71924100 @default.
• W1971270048 hasConcept C90924648 @default.
• W1971270048 hasConceptScore W1971270048C126322002 @default.
• W1971270048 hasConceptScore W1971270048C203014093 @default.
• W1971270048 hasConceptScore W1971270048C2522874641 @default.
• W1971270048 hasConceptScore W1971270048C2776235749 @default.
• W1971270048 hasConceptScore W1971270048C2776408679 @default.
• W1971270048 hasConceptScore W1971270048C2776455275 @default.
• W1971270048 hasConceptScore W1971270048C2777214474 @default.
• W1971270048 hasConceptScore W1971270048C2780040827 @default.
• W1971270048 hasConceptScore W1971270048C2780559512 @default.
• W1971270048 hasConceptScore W1971270048C71924100 @default.
• W1971270048 hasConceptScore W1971270048C90924648 @default.
• W1971270048 hasIssue "2" @default.
• W1971270048 hasLocation W19712700481 @default.
• W1971270048 hasLocation W19712700482 @default.
• W1971270048 hasLocation W19712700483 @default.
• W1971270048 hasLocation W19712700484 @default.
• W1971270048 hasOpenAccess W1971270048 @default.
• W1971270048 hasPrimaryLocation W19712700481 @default.
• W1971270048 hasRelatedWork W1538219206 @default.
• W1971270048 hasRelatedWork W1911438026 @default.
• W1971270048 hasRelatedWork W1966676395 @default.
• W1971270048 hasRelatedWork W1968813785 @default.
• W1971270048 hasRelatedWork W2001433013 @default.
• W1971270048 hasRelatedWork W2022352042 @default.
• W1971270048 hasRelatedWork W2027545702 @default.
• W1971270048 hasRelatedWork W2039885146 @default.
• W1971270048 hasRelatedWork W2053625043 @default.
• W1971270048 hasRelatedWork W2095505229 @default.

• next